Code | 6804C | ||||||||||
MA number | 44/0022/18-S | ||||||||||
Product Form: | cps dur 100x0,5 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | bottle HDPE | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.01.2018 |
Pediatric warnings: | Yes |
SPC: | SPC_Anagrelide Glenmark 0,5 mg_02.2023.pdf |
PIL: | PIL_Anagrelide Glenmark 0,5 mg_09.2023.pdf |
Safety feature | Yes |
Data update: | 16.06.2022 |